Takayama T - Search Results

1

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.

Pinyol R, Montal R, Bassaganyas L, Sia D, Takayama T, Chau GY, Mazzaferro V, Roayaie S, Lee HC, Kokudo N, Zhang Z, Torrecilla S, Moeini A, Rodriguez-Carunchio L, Gane E, Verslype C, Croitoru AE, Cillo U, de la Mata M, Lupo L, Strasser S, Park JW, Camps J, Solé M, Thung SN, Villanueva A, Pena C, Meinhardt G, Bruix J, Llovet JM. Pinyol R, et al. Among authors: takayama t. Gut. 2019 Jun;68(6):1065-1075. doi: 10.1136/gutjnl-2018-316408. Epub 2018 Aug 14. Gut. 2019. PMID: 30108162 Free PMC article. Clinical Trial.

2

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Okada S, et al. Among authors: takayama t. Gastroenterology. 1994 Jun;106(6):1618-24. doi: 10.1016/0016-5085(94)90419-7. Gastroenterology. 1994. PMID: 8194710

3

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.

Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Ishii H, et al. Among authors: takayama t. Cancer. 1996 May 1;77(9):1792-6. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1792::AID-CNCR6>3.0.CO;2-E. Cancer. 1996. PMID: 8646676

4

Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.

Ishii H, Okada S, Sato T, Nose H, Okusaka T, Yoshimori M, Takayasu K, Takayama T, Kosuge T, Yamasaki S. Ishii H, et al. Among authors: takayama t. Hepatogastroenterology. 1996 May-Jun;43(9):644-50. Hepatogastroenterology. 1996. PMID: 8799409

5

Recurrence of hepatocellular carcinoma after surgery.

Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Makuuchi M. Yamamoto J, et al. Among authors: takayama t. Br J Surg. 1996 Sep;83(9):1219-22. Br J Surg. 1996. PMID: 8983610

6

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. Takayama T, et al. Lancet. 2000 Sep 2;356(9232):802-7. doi: 10.1016/S0140-6736(00)02654-4. Lancet. 2000. PMID: 11022927 Clinical Trial.

7

Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.

Minagawa M, Makuuchi M, Takayama T, Kokudo N. Minagawa M, et al. Among authors: takayama t. Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6. Ann Surg. 2003. PMID: 14578733 Free PMC article.

8

One thousand fifty-six hepatectomies without mortality in 8 years.

Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M. Imamura H, et al. Among authors: takayama t. Arch Surg. 2003 Nov;138(11):1198-206; discussion 1206. doi: 10.1001/archsurg.138.11.1198. Arch Surg. 2003. PMID: 14609867

9

Surgical approach to liver metastasis with hepatic hilar invasion.

Minagawa M, Makuuchi M, Takayama T, Kokudo N. Minagawa M, et al. Among authors: takayama t. Hepatogastroenterology. 2004 Sep-Oct;51(59):1467-9. Hepatogastroenterology. 2004. PMID: 15362778

10

Prognostic impact of anatomic resection for hepatocellular carcinoma.

Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Hasegawa K, et al. Among authors: takayama t. Ann Surg. 2005 Aug;242(2):252-9. doi: 10.1097/01.sla.0000171307.37401.db. Ann Surg. 2005. PMID: 16041216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,070 results

Search Page

Filters